<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
  <title>IDIBAPS Respiratory Research Group - IAMR - News</title>
<link>http://www.idibapsrespiratoryresearch.org//news</link>
<description><![CDATA[
News
]]></description>

  <item>
	<title>Three IAMR Group Research Projects have been awarded by SEPAR in the 2011 Call for Grant Applications</title>
	<link>http://www.idibapsrespiratoryresearch.org//news/view.php?ID=97</link>
	<description><![CDATA[
<p>The IAMR research team has been successful in the 2011 call for the Spanish Society of Pneumology and Thoracic Surgery (SEPAR) - Fundació Respira grants (<a href="http://www.separ.es/">http://www.separ.es</a>). <strong>Antoni Torres, Carmen Lucena,</strong> and <strong>Beatriz Herrero </strong>obtained funding to carry out their research projects in the field of respiratory diseases.</p>
]]></description>
	<pubDate>2012-05-10 00:00:00</pubDate>
<image>
	<url>http://www.idibapsrespiratoryresearch.org/media/upload/gif//id_investigacion_editora_2_97_1.gif</url>
</image>
</item>
<item>
	<title>IAMR group incorporates a postdoctoral physician to work  on endotoxemia pneumonia-correlated applied to animal model</title>
	<link>http://www.idibapsrespiratoryresearch.org//news/view.php?ID=96</link>
	<description><![CDATA[
<p>The latest incorporation at the research group is <strong>Ernesto Crisafulli</strong>, who is a postdoctoral researcher in Respiratory Physiopathology at University of Parma (Italy). His role in our group will consist in the evaluation of an experimental research for sepsis due to severe pneumonia.<br />
&nbsp;</p>
]]></description>
	<pubDate>2012-05-04 00:00:00</pubDate>
<image>
	<url>http://www.idibapsrespiratoryresearch.org/media/upload/gif//ernestocrisafulli_2012-04-05101226_petit_editora_2_96_1.jpg</url>
</image>
</item>
<item>
	<title>IAMR group incorporates a respiratory physician for the line of VAP and the animal model</title>
	<link>http://www.idibapsrespiratoryresearch.org//news/view.php?ID=95</link>
	<description><![CDATA[
<p>The latest incorporation at the research group is <strong>Marta Di Pasquale</strong>, who has a Degree in Medicine at the University of Milano. At the moment she is attending the specialization in the respiratory area at the University of Milan. Her role in our group will consist of helping in the ventilator associated pneumonia line of research, and in the animal experimental model line as well.</p>
]]></description>
	<pubDate>2012-04-24 00:00:00</pubDate>
<image>
	<url>http://www.idibapsrespiratoryresearch.org/media/upload/gif//martadipascuale_2012-04-05101115_petita_editora_2_95_1.jpg</url>
</image>
</item>
<item>
	<title>Interview with Marc Miravitlles on Diario Médico for the review article published in The Lancet about Chronic obstructive pulmonary disease</title>
	<link>http://www.idibapsrespiratoryresearch.org//news/view.php?ID=94</link>
	<description><![CDATA[
<p>Chronic obstructive pulmonary disease is characterised by progressive airflow obstruction that is only partly reversible, inflammation in the airways, and systemic effects or comorbities. The main cause is smoking tobacco, but other factors have been identified. <a href="http://neumologia.diariomedico.com/area-cientifica/especialidades/neumologia">Go to Diario Médico</a></p>
]]></description>
	<pubDate>2012-04-11 00:00:00</pubDate>
<image>
	<url>http://www.idibapsrespiratoryresearch.org/media/upload/gif//2008-07-11hclinic476_editora_2_94_1.JPG</url>
</image>
</item>
<item>
	<title>Zinka Matkovic publishes her work entitled “Predictors of Adverse Outcome in Patients Hospitalised for Exacerbation of Chronic Obstructive Pulmonary Disease” in The Journal Respiration</title>
	<link>http://www.idibapsrespiratoryresearch.org//news/view.php?ID=93</link>
	<description><![CDATA[
<p>Patients with previous exacerbation of chronic obstructive pulmonary disease (COPD), hypercapnia and hypoxaemia had the highest risk of an unfavourable evolution. This is the main conclusion of the manuscript recently published in Respiration and signed by: <strong>Matkovic Z, Huerta A, Soler N, Domingo R, Gabarrús A, Torres A, Miravitlles M</strong>. To draw this conclusion authors prospectively evaluated demographic and clinical parameters, including different multidimensional prognostic scores in patients admitted for exacerbation of COPD.</p>
]]></description>
	<pubDate>2012-04-03 00:00:00</pubDate>
<image>
	<url>http://www.idibapsrespiratoryresearch.org/media/upload/gif//dsc_23751_editora_2_93_1.jpg</url>
</image>
</item>

</channel>
</rss>
